1. Home
  2. AIMD vs MNDR Comparison

AIMD vs MNDR Comparison

Compare AIMD & MNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • MNDR
  • Stock Information
  • Founded
  • AIMD 1984
  • MNDR 2016
  • Country
  • AIMD United States
  • MNDR Singapore
  • Employees
  • AIMD N/A
  • MNDR N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • MNDR
  • Sector
  • AIMD Health Care
  • MNDR
  • Exchange
  • AIMD Nasdaq
  • MNDR Nasdaq
  • Market Cap
  • AIMD 8.2M
  • MNDR 6.8M
  • IPO Year
  • AIMD N/A
  • MNDR 2024
  • Fundamental
  • Price
  • AIMD $0.51
  • MNDR $1.12
  • Analyst Decision
  • AIMD
  • MNDR
  • Analyst Count
  • AIMD 0
  • MNDR 0
  • Target Price
  • AIMD N/A
  • MNDR N/A
  • AVG Volume (30 Days)
  • AIMD 259.6K
  • MNDR 206.9K
  • Earning Date
  • AIMD 08-04-2025
  • MNDR 06-16-2025
  • Dividend Yield
  • AIMD N/A
  • MNDR N/A
  • EPS Growth
  • AIMD N/A
  • MNDR N/A
  • EPS
  • AIMD N/A
  • MNDR N/A
  • Revenue
  • AIMD $106,207.00
  • MNDR $11,600,567.00
  • Revenue This Year
  • AIMD N/A
  • MNDR $188,831.77
  • Revenue Next Year
  • AIMD N/A
  • MNDR $76.44
  • P/E Ratio
  • AIMD N/A
  • MNDR N/A
  • Revenue Growth
  • AIMD 13.38
  • MNDR 0.61
  • 52 Week Low
  • AIMD $0.40
  • MNDR $1.08
  • 52 Week High
  • AIMD $1.07
  • MNDR $12.72
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 38.36
  • MNDR N/A
  • Support Level
  • AIMD $0.49
  • MNDR N/A
  • Resistance Level
  • AIMD $0.52
  • MNDR N/A
  • Average True Range (ATR)
  • AIMD 0.05
  • MNDR 0.00
  • MACD
  • AIMD -0.01
  • MNDR 0.00
  • Stochastic Oscillator
  • AIMD 12.55
  • MNDR 0.00

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About MNDR Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.

Share on Social Networks: